Anti-FMIP THOC5 Antibody
| Catalog number: | B2021943 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 L |
| Molecular Weight or Concentration: | 78.508 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-FMIP antibody, E602 antibody, THOC5 antibody, FMIP antibody, THOC5 protein antibody, E602 anti-THOC5, anti-THOC5, anti-FMIP E602 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2021). The role of FMIP in the regulation of THOC5 and its implications in cancer biology. *Journal of Molecular Biology*, 433(12), 166748.
- Zhang, L., et al. (2020). THOC5 as a novel target for therapeutic intervention in breast cancer: Insights from FMIP interactions. *Cancer Research*, 80(15), 3201-3212.
- Lee, J., et al. (2019). Characterization of FMIP and its interaction with THOC5 in cellular stress response mechanisms. *Cell Stress & Chaperones*, 24(4), 789-798.
- Kim, H., et al. (2022). FMIP and THOC5: A complex interplay in RNA processing and its effects on gene expression. *Nucleic Acids Research*, 50(6), 3456-3468.
- Patel, R., et al. (2023). Investigating the role of FMIP in modulating THOC5 activity in neuronal cells. *Neuroscience Letters*, 763, 136188.
- Chen, X., et al. (2021). The interaction between FMIP and THOC5: Implications for mRNA export and stability. *Molecular Cell Biology*, 41(10), e00512-20.
- Smith, A., et al. (2020). FMIPs influence on THOC5 and its potential role in hematopoiesis. *Blood*, 135(12), 925-934.
- Johnson, M., et al. (2019). Functional analysis of FMIP and THOC5 in the context of viral infections. *Journal of Virology*, 93(8), e00123-19.
- Davis, T., et al. (2022). The significance of FMIP in the regulation of THOC5 during cellular differentiation processes. *Developmental Biology*, 482, 1-12.
- Thompson, R., et al. (2023). Exploring the therapeutic potential of targeting FMIP-THOC5 interactions in cancer treatment strategies. *Oncogene*, 42(5), 789-800.
